Search clinical trials for: GX-188E administered by electroporation

Total 59 results

Genexine, Inc.

Unknown

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation (GX-188E)

Cervical Intraepithelial Neoplasia 3

Korea, Republic of
Genexine, Inc.

Unknown

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Cervical Intraepithelial Neoplasia 3

Korea, Republic of
Genexine, Inc.

Completed

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3 (CIN3)

Cervical Intraepithelial Neoplasia 3

Korea, Republic of
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD06 DNA Plasmid for HCC After Radical Resection

Hepatocellular Carcinoma

China
Yonsei University

Withdrawn

Safety and Immunogenicity Study of GX-70 in TB Patient

Pulmonary Tuberculoses | Treatment Failure | High Risk Factors for Relapse
Yonsei University

Recruiting

Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer (GENUINE)

Head and Neck Squamous Cell Carcinoma

Korea, Republic of
Seoul St. Mary's Hospital
Genexine, Inc.

Unknown

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

Cervical Intraepithelial Neoplasia 3

Korea, Republic of
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

High-grade Squamous Intraepithelial Lesion (HSIL)

China
Quantum Genomics SA

Completed

Firibastat in Treatment-resistant Hypertension (FRESH)

Hypertension

United States, Czechia, France, Germany, Poland, Spain
Yonsei University

Recruiting

HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy (TRINITY)

Head and Neck Squamous Cell Carcinoma

Korea, Republic of
Genexine, Inc.

Completed

Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

Korea, Republic of
Genexine, Inc.

Unknown

Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)

Cervical Intraepithelial Neoplasia

Korea, Republic of, Estonia, Ukraine
Novo Nordisk A/S

Completed

A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Healthy Volunteers Diabetes Mellitus, Type 2 | Healthy Volunteers Overweight | Healthy Volunteers Obesity

Netherlands
Novo Nordisk A/S

Terminated

A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

Obesity | Overweight

Germany
Novo Nordisk A/S

Completed

A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens

Obesity | Overweight

Germany
Novo Nordisk A/S

Completed

A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Healthy Volunteers Diabetes Mellitus, Type 2 | Healthy Volunteers Overweight | Healthy Volunteers Obesity

Netherlands
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma

Multiple Myeloma

Belgium, France, Germany
Genexine, Inc.
Merck Sharp & Dohme LLC

Completed

The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer

Cervical Cancer

Korea, Republic of
Sunovion Respiratory Development Inc.

Completed

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease (COPD)

United States
PowderMed

Completed

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

HSV-2

United States
PowderMed

Completed

Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection

Chronic Hepatitis B

Thailand, Hong Kong, Singapore, Taiwan
Alnylam Pharmaceuticals

Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

TTR-mediated Amyloidosis

Portugal, Sweden, Brazil, United States, France, Spain, Germany
Beth Israel Deaconess Medical Center

Completed

Efficacy of Transversus Abdominis Plane (TAP) Block Techniques: Surgeon vs Anesthesia - Ultrasound Guidance

Post Operative Analgesia | Non-inferiority Trial

United States
The Hospital for Sick Children

Unknown

Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration

Meconium Aspiration Syndrome

Canada
Prometheus Biosciences, Inc., a subsidiary of Merck...

Active, not recruiting

A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease (APOLLO-CD)

Crohn Disease

United States, Australia, Belgium, Canada, Czechia, France, Georgia, Poland
PowderMed

Completed

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

HSV-2

United States
Children's Hospital Medical Center, Cincinnati
National Heart, Lung, and Blood Institute (NHLBI); University of South Florida

Recruiting

Safety and Efficacy of PMT Therapy of hPAP

Hereditary Pulmonary Alveolar Proteinosis

United States
PowderMed

Completed

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

Influenza (Pandemic)

United Kingdom
PowderMed

Completed

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

Influenza

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit

Gram-Positive Bacterial Infections

Korea, Republic of
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Cystic Fibrosis

Czechia, Moldova, Republic of, Slovakia
Fondation Ophtalmologique Adolphe de Rothschild

Withdrawn

Evaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real Life (NEPALE)

HIV+ Patients
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults

Zika Virus

United States
Mercy Research

Completed

Patient Anxiety Associated With Lymphedema Surveillance Method

Anxiety

United States
MedImmune LLC
Thrombolysis in Myocardial Infarction (TIMI) Study Group

Completed

A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction (REAL-TIMI 63B)

ST Elevation Myocardial Infarction

Netherlands, United Kingdom, Brazil, Spain, Slovakia, Israel, Czechia, Hungary, Poland, Russian Federation
Karolinska Institutet

Completed

Comparison Between Analog Neurocognitive Tests Conducted by a Trained Test Leader Versus Self-administered Digital Tests (PICASU-Eq)

Feasibility | Costs | Neurocognitive Decline | Interviews

Sweden
University of Oxford

Completed

A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates (VAC045)

Plasmodium Falciparum Malaria

United Kingdom
Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje...
Charles University, Czech Republic

Completed

Sufentanil Used by Paramedics to Treat Pain in Acute Trauma

Pain | Trauma Injury

Czechia
Medical University of Warsaw

Completed

Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma

Asthma | Cough Variant Asthma

Poland
University of Oxford

Completed

A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1

Plasmodium Falciparum Malaria

United Kingdom
Hospital Beatriz Ângelo

Completed

Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial

Digestive System Diseases | Colonoscopy Sedation

Portugal
Southeast Renal Research Institute

Withdrawn

Vitamin D and Carboxy PTH Fragments in Coronary Calcification

Endstage Renal Disease | Coronary Calcification | Parathyroid Hormone

United States
Dance Biopharm Inc.
Profil Institut für Stoffwechselforschung GmbH

Completed

Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus

Germany
University of Alberta

Completed

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry

Sedative Adverse Reaction

Canada, New Zealand
Aquilon Pharmaceuticals S.A.

Completed

Single-dose AQ001S PK Study in Healthy Volunteers (BORA)

Pharmacokinetics

Bulgaria
DUYGU DEMİROZ
Inonu University

Completed

Lean Body Weight-adjusted Rocuronium Dose and Intubation Conditions (LBW)

Body Weight Changes | Intubation Conditions | Rocuronium

Turkey
Vabiotech
Vietstar Biomedical Research

Completed

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B

Vietnam
Essen Biotech

Not yet recruiting

Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease (BAH243)

Sickle Cell Disease | Sickle-Cell Disease With Crisis

China
Morphotek

Terminated

An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer (FAR-122)

Ovarian Cancer

Canada, United States, Netherlands, Spain, Belgium, Australia
Merck Sharp & Dohme LLC

Terminated

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Breast Cancer | Colorectal Cancer | Non-small-cell Lung Carcinoma

3

Subscribe